A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2011
08/24/2011	CN101528715B 2-phenyl-6-aminocarbonyl-pyrimidine derivatives
08/24/2011	CN101500582B Use of escin
08/24/2011	CN101486771B Duchesnea polysaccharide, as well as preparation and use thereof
08/24/2011	CN101485876B Preparation method of Chinese medicine emplastrum for expelling rheumatism and relieving pain
08/24/2011	CN101485799B Paste capable of dispelling pain and eliminating cancer
08/24/2011	CN101472580B Therapeutic or prophylactic agent for allergic dermatitis
08/24/2011	CN101428124B Preparation method of plaster for strongly improving phylactic power
08/24/2011	CN101415685B Kinase inhibitors and methods of use thereof
08/24/2011	CN101410385B Benzothiazoles having histamine H3 receptor activity
08/24/2011	CN101406630B Medicament for treating coronary heart disease
08/24/2011	CN101406609B External-use medicament for treating breast inflammation of milk cattle
08/24/2011	CN101372514B Scaphium scaphigerum polysaccharide, preparation and use thereof
08/24/2011	CN101371917B Brain protein hydrolysate sodium chloride injection
08/24/2011	CN101366702B Orally taken or buccal antiviral medicament-Ribavirin tablet and method of preparing the same
08/24/2011	CN101312967B Carbamate compounds as 5-ht4 receptor agonists
08/24/2011	CN101293830B 1-oxygen-[3-aryl substituted-alkene propionyl]quinic acid compounds and uses
08/24/2011	CN101284066B Suppositorium for treating gynaecologic inflammation
08/24/2011	CN101248061B Hydrates of alkaline-earth salts of irbesartan and the preparation thereof
08/24/2011	CN101244130B Compound centipede ethanol medicine paste for preventing trauma skin cicatrix
08/24/2011	CN101242822B Medicine of ovarian cancer
08/24/2011	CN101229167B Method of preparing sodium levofolinate and applications thereof on preparing tumour-curing medicines
08/24/2011	CN101166706B Hydroquinone long-chain derivative and/or phenoxy long-chain derivative, and pharmaceutical preparation comprising the same
08/24/2011	CN101102776B Antitumor agent
08/24/2011	CN101084231B Phosphoindoles as HIV inhibitors
08/24/2011	CN101081834B Process for the preparation of leukotriene antagonists
08/24/2011	CN100999519B (-) poly thaazoleazine methylsulfonate, its preparation process and use
08/24/2011	CN100998648B Method for preparing compound red-rooted salvia enteric tablet
08/23/2011	USRE42645 Nutritional or therapeutic compositions and methods to increase bodily glutathione levels
08/23/2011	US8003823 Halo active aromatic sulfonamide organic compounds and odor control uses therefor
08/23/2011	US8003819 Proteasome inhibitors
08/23/2011	US8003812 C10 cyclopentyl ester substituted taxanes
08/23/2011	US8003811 Nitric oxide donor compounds
08/23/2011	US8003806 Integrin antagonists useful as anticancer agents
08/23/2011	US8003805 N3 alkylated benzimidazole derivatives as MEK inhibitors
08/23/2011	US8003799 Picolinic acid derivatives and their use as fungicides
08/23/2011	US8003792 Bicyclic anilide spirolactam CGRP receptor antagonists
08/23/2011	US8003791 Boronic ester and acid compounds, synthesis and uses
08/23/2011	US8003789 Activity against strains having acquired resistance nonnucleoside reverse transcriptase inhibitors; human alpha1 acid glycoprotein nonbinding; such as 4-[[(5-bromo-4,6-dichloro)-2-pyrimidinyl]amino]-benzonitrile
08/23/2011	US8003784 Cyanopyrrole containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same
08/23/2011	US8003783 Steroid 17 beta -hydroxysteroid dehydrogenase inhibitors substituted with one or more oxime groups, especially aromatase inhibitors used in the treatment of endocrine-dependent tumors, especially breast cancer
08/23/2011	US8003782 Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
08/23/2011	US8003771 Compositions, probes and conjugates and uses thereof
08/23/2011	US8003758 BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells
08/23/2011	US8003706 Enhanced production of blood clotting factors and fibrin fabric
08/23/2011	US8003704 Tryptophan metabolite as aldehyde dehydrogenase inhibitor; side effect reduction
08/23/2011	US8003703 Phenoxiacetic acid derivatives
08/23/2011	US8003702 Substituted aryl-indole compounds and their kynurenine/kynuramine-like metabolites as therapeutic agents
08/23/2011	US8003701 Method of inhibiting inflammatory pain
08/23/2011	US8003700 Colchicine solid complex; methods of making; and methods of use thereof
08/23/2011	US8003698 Site-specific inhibitors of histone methyltransferase (HMTASE) and process of preparation thereof
08/23/2011	US8003697 Disodium salts, monohydrates, and ethanol solvates for delivering active agents
08/23/2011	US8003695 IKK-beta serine-threonine protein kinase inhibitors
08/23/2011	US8003694 Crystal of hydroxynorephedrin derivative hydrochloride ¼ hydrate
08/23/2011	US8003693 Modulation of anxiety through blockade of anandamide hydrolysis
08/23/2011	US8003692 Methods and compositions to inhibit edema factor and adenylyl cyclase
08/23/2011	US8003691 Tuberculosis therapy; mixture of cantharidic anhydride in vegetable oil; solvent extraction of plant extracts
08/23/2011	US8003690 Topical nanoparticulate spironolactone formulation
08/23/2011	US8003689 Metabolites of selective androgen receptor modulators and methods of use thereof
08/23/2011	US8003688 Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract
08/23/2011	US8003687 Esters of compounds in the leptomycin family
08/23/2011	US8003686 Aryl derivatives of curcumin, demethoxycurcumin, bisdemethoxycurcumin or curcuminisoxazolide and their use as animal feed additives
08/23/2011	US8003685 Thiophene analogues for the treatment or prevention of flavivirus infections
08/23/2011	US8003684 Crystal form and pharmaceutical compositions of (+)-R-zileuton
08/23/2011	US8003683 Acetylated amino acids as anti-platelet agents, nutritional and vitamin supplements
08/23/2011	US8003682 Indole compounds, a process for their preparation and pharmaceutical compositions containing them
08/23/2011	US8003681 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)acetic acid and methyl ester
08/23/2011	US8003680 Therapeutic compounds
08/23/2011	US8003679 Treating stroke or reccurence with an ACE inhibitor selected from quinapril, captropril, lisinopril, perindopril, trandolapril, enalapril, moexipril, fosinopril, ramipril, cilazapril, imidapril, spirapril, temocapril, benazepril, alacepril, ceronapril, delapril, moveltipril and trandolapril
08/23/2011	US8003678 Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds
08/23/2011	US8003677 2-heteroaryl-pyrrolo[3,4-c]pyrrole derivatives and their use as SCD inhibitors
08/23/2011	US8003676 1,3,4-oxadiazole derivatives as DGAT1 inhibitors
08/23/2011	US8003675 3,4-dihalogenoisothiazole derivative, and agricultural or horticultural plant disease-controlling agent
08/23/2011	US8003674 Flavivirus inhibition by sultams and related compounds
08/23/2011	US8003673 Daptomycin for the treatment of biofilm and catheter salvage
08/23/2011	US8003672 CB-1 receptor modulator formulations
08/23/2011	US8003670 Aminoalkoxy aryl sulfonamide compounds and their use as 5-HT6 ligands
08/23/2011	US8003669 Remedy for sleep disturbance
08/23/2011	US8003668 Use of 2-(amino-substituted piperidin-1-yl)benzimidazoles as antidiabetic agents, or to treat carbohydrate and lipid metabolic disorders; use in combination with other drugs; N-[2-(3-Aminopiperidin-1-yl)-1-(3-methylbut-2-enyl)-1H-benzimidazol-6-yl]-benzenesulfonamide or salts for example
08/23/2011	US8003666 Hydrate for medical purposes
08/23/2011	US8003665 Salts and polymorphs of a potent antidiabetic compound
08/23/2011	US8003663 Pyrazolo[3,4-b]pyridine compounds, and their use as PDE4 inhibitors
08/23/2011	US8003662 Heterobicyclic thiophene compounds and methods of use
08/23/2011	US8003661 Naphthalene and quinoline sulfonylurea derivatives as EP4 receptor antagonists
08/23/2011	US8003660 Modulators of muscarinic receptors
08/23/2011	US8003659 Macrocyclic serine protease inhibitors
08/23/2011	US8003658 Quinazoline derivatives for inhibiting cancer cell growth and method for the preparation thereof
08/23/2011	US8003657 Heterocyclic substituted bisarylurea derivatives
08/23/2011	US8003656 2-phenoxy pyrimidinone analogues
08/23/2011	US8003654 N-glycinsulfonamide derivatives and uses as orexin receptor antagonists
08/23/2011	US8003653 Imidazolidinone compounds useful as β-secretase inhibitors for the treatment of Alzheimer's disease
08/23/2011	US8003652 Dietetics; cancer
08/23/2011	US8003651 Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
08/23/2011	US8003650 Hydrazide compound and harmful arthropod-controlling agent containing the same
08/23/2011	US8003649 Bicyclic derivatives for use in the treatment of androgen receptor associated conditions-155
08/23/2011	US8003648 Heterocyclic GPR40 modulators
08/23/2011	US8003647 (Aza)indole derivative and use thereof for medical purposes
08/23/2011	US8003646 Substituted triazolo-pyridazine derivatives
08/23/2011	US8003645 type II diabetes; 6-Ethyl-N,N'-bis(3-hydroxyphenyl)-1,3,5-triazine-2,4-diamine; suppress the fall in MTT reduction capacity by beta -amyloid protein; inhibit impairment of long-term potentiation of hippocampal nerve cells, pyrimidine or 1,3,5 triazine derivatives
08/23/2011	US8003644 Solid biocide formulations
08/23/2011	US8003643 Inhibitors of Akt activity

1 ... 1596 1597 1598 1599 1600 1601 1602 1603 1604 1605 1606 1607 1608 1609 1610 1611 1612 1613 1614 1615 1616 ... 7860